We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
(+10%)
Cap. Flow
+$798M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$65.3M |
| 2 |
Amazon
AMZN
|
+$50M |
| 3 |
Tesla
TSLA
|
+$30.5M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$26.6M |
| 5 |
EPAM Systems
EPAM
|
+$26.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KSU
Kansas City Southern
KSU
|
+$39.1M |
| 2 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$31.2M |
| 3 |
XEC
CIMAREX ENERGY CO
XEC
|
+$23.4M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$21.9M |
| 5 |
SBNY
Signature Bank
SBNY
|
+$17.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.54% |
| 2 | Financials | 13.15% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Health Catalyst
HCAT
$128M
| $1.95M | ﹤0.01% |
49,095
+409
| +0.8% | +$18.6K |
|
1902
BioLife Solutions
BLFS
$1.7B
| $1.94M | ﹤0.01% |
52,072
-7,722
| -13% | -$331K |
|
1903
Myers Industries
MYE
$1.29B
| $1.94M | ﹤0.01% |
96,996
-857
| -0.9% | -$17.3K |
|
|
GPMT
1904
Granite Point Mortgage Trust
GPMT
$61.2M
| $1.94M | ﹤0.01% |
165,526
-1,323
| -0.8% | -$16.9K |
|
|
ENDP
1905
DELISTED
Endo International plc
ENDP
| $1.93M | ﹤0.01% |
513,894
-13,190
| -3% | -$63.9K |
|
1906
Celldex Therapeutics
CLDX
$3.28B
| $1.93M | ﹤0.01% |
49,823
+558
| +1% | +$24.3K |
|
1907
Schneider National
SNDR
$6.25B
| $1.93M | ﹤0.01% |
71,522
-1,872
| -3% | -$47K |
|
1908
Hawkins
HWKN
$2.71B
| $1.92M | ﹤0.01% |
48,713
+1
| +0% | +$37 |
|
1909
Coinbase
COIN
$40.5B
| $1.92M | ﹤0.01% |
7,597
+12
| +0.2% | +$3.49K |
|
1910
Stride
LRN
$3.43B
| $1.92M | ﹤0.01% |
57,488
+368
| +0.6% | +$12.7K |
|
|
CHS
1911
DELISTED
Chicos FAS, Inc.
CHS
| $1.91M | ﹤0.01% |
355,776
-3,240
| -0.9% | -$17.6K |
|
|
ARCH
1912
DELISTED
Arch Resources, Inc.
ARCH
| $1.91M | ﹤0.01% |
20,951
-554
| -3% | -$49.2K |
|
1913
Editas Medicine
EDIT
$442M
| $1.91M | ﹤0.01% |
71,969
-1,902
| -3% | -$65.5K |
|
1914
Par Pacific Holdings
PARR
$3.32B
| $1.9M | ﹤0.01% |
115,019
+1,233
| +1% | +$18.6K |
|
1915
Rocket Companies
RKT
$38.9B
| $1.9M | ﹤0.01% |
135,442
-2,888
| -2% | -$46K |
|
1916
OceanFirst Financial
OCFC
$1.91B
| $1.89M | ﹤0.01% |
85,114
-1,544
| -2% | -$33.7K |
|
1917
Repay Holdings
RPAY
$327M
| $1.88M | ﹤0.01% |
102,783
+336
| +0.3% | +$6.6K |
|
1918
iShares S&P 500 Value ETF
IVE
$49.8B
| $1.87M | ﹤0.01% |
11,958
| – | – |
|
1919
Golar LNG
GLNG
$5.13B
| $1.87M | ﹤0.01% |
151,106
-1,775
| -1% | -$22.6K |
|
|
CSII
1920
DELISTED
Cardiovascular Systems, Inc.
CSII
| $1.87M | ﹤0.01% |
99,634
+566
| +0.6% | +$15.1K |
|
|
CTO
1921
CTO Realty Growth
CTO
$815M
| $1.87M | ﹤0.01% |
91,296
+246
| +0.3% | +$4.56K |
|
|
SHYF
1922
DELISTED
The Shyft Group
SHYF
| $1.87M | ﹤0.01% |
38,051
-71
| -0.2% | -$3.25K |
|
1923
WisdomTree
WT
$3.22B
| $1.86M | ﹤0.01% |
304,381
-4,864
| -2% | -$30.1K |
|
1924
DMC Global
BOOM
$157M
| $1.86M | ﹤0.01% |
47,002
+3,137
| +7% | +$125K |
|
1925
Ethan Allen Interiors
ETD
$603M
| $1.86M | ﹤0.01% |
70,691
+2,431
| +4% | +$59.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2021 Portfolio in Review
As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
- RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
- RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
- RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
- RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.
Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.